NEWS
Alzheimer’s disease could be ‘halted’ using hyperbaric oxygen therapy
MELBOURNE: Alzheimer’s disease could be delayed or even reversed by giving oxygen therapy to patients… read more
Biotech outfit Neuren rattles tin for equity via Bell Potter
MELBOURNE: Bankers for clinical-stage biotech company Neuren Pharmaceuticals will be pounding the virtual pavement on… read more
VBreathe investors lock in for $10 million capital raising
MELBOURNE: Air purification and detoxification technology company VBreathe is raising up to $10 million in… read more
TPG Capital’s Novotech makes $5b pitch to fund managers
SYDNEY: Australian born and bred clinical research company Novotech has kicked off its mooted Hong… read more
